Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
about
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Controlling cytomegalovirus: helping the immune system take the leadLegionella jordanis in hematopoietic SCT patients radiographically mimicking invasive mold infection.Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients.Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationCytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesisCytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patientsPhase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus.Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8+ T cells by flow cytometry.Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence.High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation.Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV-seropositive patients after allogeneic hematopoietic cell transplantation.Successful treatment of cytomegalovirus enteritis after unrelated allogeneic stem cell transplantation by the infusion of ex vivo-expanded CD4+ lymphocytes derived from the recipient's peripheral blood donor cells.Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation.Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.Measuring T-cell responses against LCV and CMV in cynomolgus macaques using ELISPOT: potential application to non-clinical testing of immunomodulatory therapeutics.Bullous pemphigoid complicated by cytomegalovirus disease as a manifestation of immune reconstitution inflammatory syndrome: retrospective analyses of our institutional cases and literature review.Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.
P2860
Q30608976-6CE9F7E0-DFC1-47C1-951F-59BC709FCDECQ33820695-66C03366-B54D-4965-96C2-62ED3F138CD9Q34185101-89E2D2FC-2B6F-4FA0-84A9-27E83F011BDEQ34432181-75159D57-05EC-42CD-B787-D85A825BD03AQ34524941-C96F7A42-6FA8-46DE-A306-EDFB1E14E736Q34649004-14656369-132D-4F2F-9711-25ED384CFE90Q34798117-DC50CBA7-A547-4EE9-860D-AA4E5EA66C0CQ34813063-FEEBF803-43DE-4545-B441-FDD6452E407CQ35115725-486157F9-F77C-4130-8394-DDE4301DCAA9Q35767479-8A872C24-7F59-4682-AE26-FEC6F3372DA7Q35859879-C04E1181-97D3-4922-B11E-6C589AB60F36Q36305254-23ACFA27-8B3C-4F23-B01C-BA651377540AQ36559052-85DF1FA1-114A-4A92-8A36-4FF12A28D86EQ37619850-140820A2-725C-4A42-8626-891292DBADD3Q38002109-96746142-4BE9-4264-8BE6-A815C7EA0B91Q38779846-A6EFA847-1372-4033-9CD4-DA6D3A592262Q38902980-D632B2C3-7FD9-4EFE-A873-4A5C21167558Q39230416-22B8FD19-F486-40D3-9D49-C06F17D55BD8Q40128190-E7616C5C-41D7-4C8C-BA00-BC2D0DF94162Q40202358-B2ABD4D3-B27D-4811-B36A-A2F11C4D48A0Q40419511-87893447-75E4-45BA-8DD1-F0F31AB403A2Q41099371-4D11E7FC-0AAC-4F77-ADDA-B11A34A4A7C6Q41260045-E81CA047-E4CB-4F03-BA53-05E3066855F2Q42110100-84A64E34-882C-4DE5-B8DA-62CE1D821CD0Q42182292-85590053-0C71-416A-86A7-ABC7C062833FQ42258301-B4E2A3A9-83FB-490E-A7D6-78C4657B433DQ42277578-F297B80F-F145-4DF5-BF34-0AB1D9CF048AQ45905220-0E552132-1AB2-4934-84AD-504A0AEDCE48Q47570415-3C614B0E-78FD-4DF7-B0A2-373BA4346F92Q53005441-C68AEA96-9FA2-4A9F-800C-E0841A7D26EA
P2860
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@en
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@nl
type
label
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@en
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@nl
prefLabel
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@en
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@nl
P2860
P1476
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation.
@en
P2093
Takehiko Mori
P2860
P2888
P304
P356
10.1007/S12185-010-0569-X
P577
2010-04-23T00:00:00Z